LIPO
Lipella Pharmaceuticals Inc.
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.00
Day high
0.06
Day low
0.03
Volume
160.09K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.64
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+100.00%
+101.4%
1M
-99.42%
-103.2%
3M
-99.05%
-102.1%
6M
-99.84%
-110.9%
YTD
-99.78%
-112.1%
1Y
-99.93%
-119.9%
3Y
-100.00%
-174.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Total revenue | $536.36K | $449.62K | $184.16K | $259.35K | +19.3% |
| Operating revenue | $536.36K | $449.62K | $0 | $0 | +19.3% |
| Cost of revenue | $3.61M | $3.04M | $2.55M | $1.46M | +18.9% |
| Gross profit | -$3.08M | -$2.59M | -$2.36M | -$1.20M | -18.8% |
| Research & development | — | — | $2.55M | $1.46M | — |
| Selling, general & admin | $2.00M | $2.16M | $226.19K | $718.38K | -7.1% |
| Total operating expense | $2.00M | $2.16M | $226.19K | $718.38K | -7.1% |
| Operating income | -$5.08M | -$4.75M | -$2.59M | -$1.92M | -7.0% |
| Net interest income | $64.28K | $126.99K | -$7.93K | -$6.73K | -49.4% |
| Pre-tax income | -$5.02M | -$4.62M | -$2.60M | -$1.87M | -8.6% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$5.02M | -$4.62M | -$2.60M | -$1.87M | -8.6% |
| Net income to common | -$5.02M | -$4.62M | -$2.60M | -$1.87M | -8.6% |
| Basic EPS | -4.79 | -6.16 | -5.12 | -2.60 | +22.2% |
| Diluted EPS | -4.79 | -6.16 | -5.12 | -2.60 | +22.2% |
| EBIT | -$5.02M | -$4.61M | -$2.59M | -$1.86M | -8.9% |
| EBITDA | -$5.01M | -$4.61M | -$2.59M | -$1.86M | -8.8% |
| Basic shares | 1.05M | 750.38K | 507.58K | 717.99K | +39.7% |
| Diluted shares | 1.05M | 750.38K | 507.58K | 717.99K | +39.7% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.18M | $3.29M | $5.12M | $1.41M | -33.7% |
| Cash & short-term investments | $2.18M | $3.29M | $5.12M | $1.71M | -33.7% |
| Total current assets | $2.62M | $3.43M | $5.80M | $1.81M | -23.7% |
| Property, plant & equipment | $56.62K | $147.89K | $150.82K | $204.80K | -61.7% |
| Total assets | $2.67M | $3.58M | $5.95M | $2.01M | -25.3% |
| Total current liabilities | $754.42K | $385.36K | $1.18M | $340.63K | +95.8% |
| Current debt | — | — | $275.00K | $25.00K | — |
| Long-term debt | — | — | — | $50.00K | — |
| Total debt | $47.60K | $136.59K | $429.52K | $282.96K | -65.1% |
| Total liabilities | $754.42K | $432.73K | $1.27M | $589.34K | +74.3% |
| Retained earnings | -$15.34M | -$10.32M | -$5.70M | -$3.11M | -48.6% |
| Shareholder equity | $1.92M | $3.14M | $4.68M | $1.42M | -39.0% |
| Working capital | $1.86M | $3.04M | $4.62M | $1.47M | -38.8% |
| Net tangible assets | $1.92M | $3.14M | $4.68M | $1.42M | -39.0% |
| Shares issued | 1.21M | 756.74K | 717.99K | 717.99K | +59.8% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Net income | -$5.02M | -$4.62M | -$2.60M | -$1.87M | -8.6% |
| Depreciation & amortisation | $2.89K | $1.69K | $0 | — | +71.3% |
| Stock-based compensation | $749.40K | $1.36M | $747.40K | $728.80K | -44.7% |
| Change in working capital | $113.23K | -$9.11K | $9.52K | $197.61K | +1,343.2% |
| Operating cash flow | -$3.95M | -$3.15M | -$1.83M | -$989.27K | -25.4% |
| Capital expenditure | — | -$14.43K | — | — | — |
| Investing cash flow | $0 | -$14.43K | $300.55K | -$300.55K | +100.0% |
| Financing cash flow | $2.84M | $1.34M | $5.24M | $2.10M | +112.6% |
| Free cash flow | -$3.95M | -$3.16M | -$1.83M | -$989.27K | -24.8% |
| End cash position | $2.18M | $3.29M | $5.12M | $1.41M | -33.7% |
| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $173.67K | — |
| Operating revenue | $0 | $0 | $0 | $173.67K | — |
| Cost of revenue | $720.97K | $791.58K | $993.48K | $1.06M | -8.9% |
| Gross profit | -$720.97K | -$791.58K | -$993.48K | -$888.67K | +8.9% |
| Selling, general & admin | $553.30K | $651.72K | $463.74K | $562.62K | -15.1% |
| Total operating expense | $553.30K | $564.99K | $334.35K | $925.31K | -2.1% |
| Operating income | -$1.27M | -$1.36M | -$1.33M | -$1.81M | +6.1% |
| Net interest income | $20.19K | $29.09K | $21.30K | $9.62K | -30.6% |
| Pre-tax income | -$1.25M | -$1.33M | -$1.31M | -$1.44M | +5.5% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$1.25M | -$1.33M | -$1.31M | -$1.44M | +5.5% |
| Net income to common | -$1.25M | -$1.33M | -$1.31M | -$1.44M | +5.5% |
| Basic EPS | -0.28 | -0.31 | -0.64 | — | +9.7% |
| Diluted EPS | -0.28 | -0.31 | -0.64 | — | +9.7% |
| EBIT | -$1.27M | -$1.36M | -$1.33M | -$1.44M | +6.1% |
| EBITDA | -$1.27M | -$1.36M | -$1.33M | -$1.44M | +6.1% |
| Basic shares | 4.55M | 4.31M | 2.06M | — | +5.7% |
| Diluted shares | 4.55M | 4.31M | 2.06M | — | +5.7% |
| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.86M | $2.78M | $4.23M | $2.18M | -33.3% |
| Cash & short-term investments | $1.86M | $2.78M | $4.23M | $2.18M | -33.3% |
| Accounts receivable | — | — | $0 | — | — |
| Total current assets | $2.08M | $3.44M | $4.82M | $2.62M | -39.5% |
| Property, plant & equipment | $270.52K | $282.96K | $32.71K | $56.62K | -4.4% |
| Total assets | $2.35M | $3.72M | $4.86M | $2.67M | -36.8% |
| Total current liabilities | $642.40K | $746.90K | $776.85K | $754.42K | -14.0% |
| Total debt | $264.08K | $274.54K | $24.00K | $47.60K | -3.8% |
| Total liabilities | $862.22K | $978.53K | $776.85K | $754.42K | -11.9% |
| Retained earnings | -$19.23M | -$17.97M | -$16.65M | -$15.34M | -7.0% |
| Shareholder equity | $1.49M | $2.74M | $4.08M | $1.92M | -45.7% |
| Working capital | $1.44M | $2.69M | $4.05M | $1.86M | -46.6% |
| Net tangible assets | $1.49M | $2.74M | $4.08M | $1.92M | -45.7% |
| Shares issued | 4.62M | 4.47M | 2.55M | 1.21M | +3.4% |
| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Net income | -$1.25M | -$1.33M | -$1.31M | -$1.44M | +5.5% |
| Depreciation & amortisation | $722 | $721 | $722 | $721 | +0.1% |
| Stock-based compensation | $0 | $0 | $0 | $80.67K | — |
| Change in working capital | $327.30K | -$106.37K | -$120.33K | $369.87K | +407.7% |
| Operating cash flow | -$926.06K | -$1.43M | -$1.43M | -$990.41K | +35.4% |
| Investing cash flow | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $0 | -$10.05K | $3.47M | $1.82M | +100.0% |
| Free cash flow | -$926.06K | -$1.43M | -$1.43M | -$990.41K | +35.4% |
| End cash position | $1.86M | $2.78M | $4.23M | $2.18M | -33.3% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
+37.93% from price
SMA 20
0.01
-96.55% from price
SMA 50
0.06
-99.28% from price
SMA 100
0.06
-99.33% from price
SMA 200
0.16
-99.75% from price
EMA 12
0.01
-92.25% from price
EMA 26
0.02
-98.19% from price
EMA 50
0.04
-99.06% from price
RSI (14)
28.4
Oversold
MACD (12,26,9)
-0.02
Hist 0.00
ATR (14)
0.00
583.93% of price
Realised vol 30D
1475.0%
Annualised
Bollinger upper
0.05
20, 2σ
Bollinger lower
-0.03
20, 2σ
50 / 200 cross
Death
0.06 vs 0.16
Trend bias
Below 200
-99.75%
Risk profile
Beta vs SPY
-2.06
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
1475.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-100.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
583.93% of price
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.